Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Stephen DuBois’s Hedge Fund Now Owns a Large Position in Ariad Pharmaceuticals

Stephen DuBois, Ariad Pharmaceuticals: In a new filing just reported to the SEC, Stephen DuBois‘s Camber Capital disclosed a new 5.4% stake in Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). This is a passive stake, but Camber does have a history of activism, most notably with Conceptus Inc. in 2011. Shares of Ariad are down 6% today, so it’s likely that the healthcare-focused hedge fund is buying the value here.

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Disclosure: none

Recommended Reading:

Following Warren Buffett Into IBM Could Be a Great Strategy

Taconic Capital Advisors Maintains Activist Stake in WPX Energy

Carl Icahn Tweets About Apple Letter, Unveils Plan to Launch New Website